Mechanistic role of obesity in benzo(a)pyrene-initiated cancer

肥胖在苯并（a）芘引发的癌症中的机制作用

• 批准号: 10214618
• 负责人: Jamie J Bernard
• 金额: $ 37.87万
• 依托单位: MICHIGAN STATE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-07-13 至 2024-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10214618
• 关键词: 4T1; Acute; Adipose tissue; Agar; Aromatic Polycyclic Hydrocarbons; Aryl Hydrocarbon Receptor; Benzo(a)pyrene; Breast Cancer Risk Factor; Breast Carcinogenesis; Breast Epithelial Cells; Cancer Burden; Carcinogens; Cells; Central obesity; Chronic; Cultured Cells; DNA Damage; Data; EPHX1 gene; Enzymes; Epoxy Compounds; Etiology; Exposure to; FGF2 gene; FGFR1 gene; Fibroblast Growth Factor Receptor 2; Fibroblasts; Gene Expression; Genetic Transcription; Growth; Growth Factor; High Fat Diet; Human; Hydrolase; In Vitro; Inbred BALB C Mice; Individual; Lead; MCF10A cells; Malignant - descriptor; Malignant Neoplasms; Mammary Tumorigenesis; Mass Spectrum Analysis; Measures; Mediating; Metabolic Pathway; Metabolism; Modeling; Mus; Nature; Obesity; Outcomes Research; Pathway interactions; Phase; Process; Receptor Activation; Receptor Signaling; Research; Risk; Role; Signal Transduction; Testing; Time; Tissues; Up-Regulation; Visceral; Work; adduct; carcinogenesis; carcinogenicity; cell transformation; disorder risk; feeding; follow-up; imaging approach; in vivo; inhibitor/antagonist; malignant breast neoplasm; mammary; mammary epithelium; multiphoton imaging; neutralizing antibody; novel; overexpression; receptor; receptor expression; receptor upregulation; release factor; transcriptome sequencing; tumor; tumorigenesis

Project Summary This R01 is about our discovery of a surprising and unexpected way in which adipose tissue increases the vulnerability of mammary epithelial cells to benzo(a)pyrene (BaP), a Group I-classified carcinogen, by inducing the aryl hydrocarbon receptor (AhR) protein. Upregulation of AhR expression and transcription is important in several, if not all, stages of malignant transformation. In particular, AhR is upregulated in human breast cancer. A major gap in AhR research is the nature of the signals that drive AhR induction and activation in breast carcinogenesis. Until now, no one might have expected that in the search for the unknown activators and inducers of AhR, that secretions from visceral adipose tissue (VAT) would be among them. Remarkably, our data shows that factors secreted from VAT can induce AhR in mammary epithelial cells, and AhR is also induced in mammary tissues of mice fed a high-fat diet. Our preliminary data also strongly suggest: 1) BaP and secretions from VAT, such as fibroblast growth factor-2 (FGF2), synergize to cause DNA damage and accelerated transformation of human mammary epithelial cells; and 2) AhR is a critical control point for BaP bioactivation in this synergistic process. Our central hypothesis is that factors secreted from human VAT will potentiate BaP metabolism by inducing AhR, resulting in increased carcinogenic metabolites (e.g. BPDE) and DNA damage, two well-known contributors to malignant transformation of human mammary epithelial cells. We will test this hypothesis in connection with human breast cancer. In aim 1, we will determine the impact of factors released from VAT on BaP metabolism and DNA damage in vitro. We will also determine what is in VAT that effects BaP metabolism and induces AhR. In aim 2, we will determine for the first time in vivo the impact of high-fat diet feeding on AhR-mediated BaP metabolism, DNA damage and mammary tumorigenesis using both acute and chronic exposures to BaP. For both aims, we will determine the role of FGFR1 signaling, the primary receptor for FGF2, on the AhR activation and metabolism of BaP using a FGFR1 inhibitor and a novel orthotopic model of FGFR1-driven mammary tumorigenesis. The expected outcomes of this research will be to identify the mechanisms and metabolic pathways by which BaP interacts with factors released from VAT in promoting DNA damage and breast cancer. BaP metabolites will be analyzed using a novel multiphoton imaging approach. Elucidating the unexpected and surprising connection between factors from human visceral adipose tissues and the bioactivation benzo(a)pyrene (BaP) will be a major advance in understanding why obesity heightens the risk of breast cancer.

项目摘要 这个R 01是关于我们发现了一个令人惊讶和意想不到的方式，脂肪组织增加了 乳腺上皮细胞对苯并（a）芘（BaP）（一种I类致癌物）的脆弱性，通过诱导 芳香烃受体（AhR）蛋白。AhR表达和转录的上调在 恶性转化的几个阶段特别是，AhR在人乳腺癌中上调。 AhR研究的一个主要空白是驱动乳腺中AhR诱导和激活的信号的性质。 致癌作用到目前为止，没有人会想到，在寻找未知的激活剂和 AhR的诱导物，内脏脂肪组织（VAT）分泌物将在其中。值得注意的是，我们 数据显示，VAT分泌的因子可以诱导乳腺上皮细胞中的AhR，并且AhR也被诱导 在高脂饮食小鼠的乳腺组织中。我们的初步数据还有力地表明：1）BaP和分泌物 从增值税，如成纤维细胞生长因子-2（FGF 2），协同作用，造成DNA损伤和加速 人乳腺上皮细胞的转化;和2）AhR是BaP生物活化的关键控制点 这个协同过程。我们的中心假设是，从人类VAT分泌的因子将增强BaP 通过诱导AhR代谢，导致致癌代谢物（如BPDE）和DNA损伤增加， 两种众所周知的导致人乳腺上皮细胞恶性转化的因素。我们将测试这个 与人类乳腺癌有关的假说。在目标1中，我们将确定释放的因素的影响 VAT对BaP代谢和DNA损伤的影响。我们还将确定增值税中影响BaP的内容 代谢并诱导AhR。在aim 2中，我们将首次在体内确定高脂饮食的影响 以AhR介导的BaP代谢、DNA损伤和乳腺肿瘤发生为基础， 长期暴露于苯并（a）芘对于这两个目标，我们将确定FGFR 1信号传导的作用， 对于FGF 2，使用FGFR 1抑制剂和新型原位模型对AhR活化和BaP代谢的影响 FGFR 1驱动的乳腺肿瘤发生。这项研究的预期结果将是确定 BaP与VAT释放的因子相互作用促进DNA合成的机制和代谢途径 损伤和乳腺癌。BaP代谢物将使用新的多光子成像方法进行分析。 阐明了来自人类内脏脂肪组织的因子与 苯并（a）芘（BaP）的生物活性将是理解肥胖为什么会增加风险的一个重大进展。 乳腺癌